Hutchmed (China) (NASDAQ: HCM)
Hutchmed (China) Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Hutchmed (China) Company Info
HUTCHMED (China) Ltd. is a holding company, which engages in the research and development, manufacture, and sale of pharmaceuticals and health oriented consumer products. It operates through the Oncology/Immunology and Other Ventures segments. The Oncology/Immunology segment covers all activities related to oncology/immunology including sales, marketing, manufacturing and research and development with respect to drugs and drug candidates. The Other Ventures segment includes all other HUTCHMED businesses. The company was founded on December 18, 2000 and is headquartered in Hong Kong.
News & Analysis
Hutchison China MediTech Limited (HCM) Q2 2019 Earnings Call Transcript
HCM earnings call for the period ending June 30, 2019.
Why Chi-Med Stock Is Tanking Today
The pricing of a secondary offering is weighing heavily on the Chinese drug stock.
Valuation
Earnings Transcripts
Hutchison China MediTech Ltd (HCM) Q2 2021 Earnings Call Transcript
HCM earnings call for the period ending June 30, 2021.
Hutchison China MediTech Limited (HCM) Q4 2020 Earnings Call Transcript
HCM earnings call for the period ending December 31, 2020.
Hutchison China MediTech Limited (HCM) Q2 2020 Earnings Call Transcript
HCM earnings call for the period ending June 30, 2020.
Hutchison China MediTech Limited (HCM) Q4 2019 Earnings Call Transcript
HCM earnings call for the period ending December 31, 2019.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.